These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33509743)

  • 41. Added Value of Concomitant Systematic and Fusion Targeted Biopsies for Grade Group Prediction Based on Radical Prostatectomy Final Pathology on Positive Magnetic Resonance Imaging.
    Ploussard G; Beauval JB; Lesourd M; Almeras C; Assoun J; Aziza R; Gautier JR; Loison G; Portalez D; Salin A; Tollon C; Soulié M; Malavaud B; Roumiguié M
    J Urol; 2019 Dec; 202(6):1182-1187. PubMed ID: 31246548
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reply to Nicola Fossati, Giorgio Gandaglia, Alberto Bossi, Francesco Montorsi, Alberto Briganti's Letter to the Editor re: Stephen J. Freedland, Voleak Choeurng, Lauren Howard, et al. Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy After Radical Prostatectomy. Eur Urol 2016;70:588-96.
    Freedland SJ; Den RB
    Eur Urol; 2016 Oct; 70(4):e110-e111. PubMed ID: 26992279
    [No Abstract]   [Full Text] [Related]  

  • 43. Re: Guillaume Ploussard, Eric Barret, Gaëlle Fiard, et al. Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsies for Prostate Cancer Diagnosis: Final Results of the Randomized PERFECT trial (CCAFU-PR1). Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2024.01.019.
    Lin FX; Yu Y; Xu ZP
    Eur Urol Oncol; 2024 May; ():. PubMed ID: 38772750
    [No Abstract]   [Full Text] [Related]  

  • 44. Reply to Francesco Montorsi, Giorgio Gandaglia, Christoph Würnschimmel, Markus Graefen, Alberto Briganti, and Hartwig Huland's Letter to the Editor re: Paolo Afonso de Carvalho, João A.B.A. Barbosa, Giuliano B. Guglielmetti, et al. Retrograde Release of the Neurovascular Bundle with Preservation of Dorsal Venous Complex During Robot-assisted Radical Prostatectomy: Optimizing Functional Outcomes. Eur Urol 2020;77:628-35. Incredible Results for Robot-assisted Nerve-sparing Radical Prostatectomy in Prostate Cancer Patients: Rio de Janeiro is Still Beautiful.
    Ferreira Coelho R; Afonso de Carvalho P; Betoni Guglielmetti G; Dener Cordeiro M; Carlos Nahas W
    Eur Urol; 2021 Feb; 79(2):e47-e49. PubMed ID: 33162248
    [No Abstract]   [Full Text] [Related]  

  • 45. Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Disease-A Risk Model for Patient-tailored Risk Stratification When Planning Radical Prostatectomy.
    Nyarangi-Dix J; Wiesenfarth M; Bonekamp D; Hitthaler B; Schütz V; Dieffenbacher S; Mueller-Wolf M; Roth W; Stenzinger A; Duensing S; Roethke M; Teber D; Schlemmer HP; Hohenfellner M; Radtke JP
    Eur Urol Focus; 2020 Nov; 6(6):1205-1212. PubMed ID: 30477971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reply to E. David Crawford and Bo-Eric Persson's letter to the editor re: Giorgio Gandaglia, Maxine Sun, Jim C. Hu, et al. Gonadotropin-releasing hormone agonists and acute kidney injury in patients with prostate cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.01.026.
    Gandaglia G; Sun M; Briganti A; Karakiewicz PI
    Eur Urol; 2014 Aug; 66(2):e36-7. PubMed ID: 24746970
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical outcomes associated with prostate cancer conspicuity on biparametric and multiparametric MRI: a protocol for a systematic review and meta-analysis of biochemical recurrence following radical prostatectomy.
    Morka N; Simpson BS; Ball R; Freeman A; Kirkham A; Kelly D; Whitaker HC; Emberton M; Norris JM
    BMJ Open; 2021 May; 11(5):e047664. PubMed ID: 33952556
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy.
    Faiena I; Salmasi A; Mendhiratta N; Markovic D; Ahuja P; Hsu W; Elashoff DA; Raman SS; Reiter RE
    J Urol; 2019 Jan; 201(1):91-97. PubMed ID: 30142318
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Utility of Multiparametric Magnetic Resonance Imaging With PI-RADS, Version 2, in Patients With Prostate Cancer Eligible for Active Surveillance: Which Radiologic Characteristics Can Predict Unfavorable Disease?
    Kim H; Pak S; Park KJ; Kim MH; Kim JK; Kim M; You D; Jeong IG; Song C; Hong JH; Kim CS; Ahn H
    Clin Genitourin Cancer; 2020 Feb; 18(1):50-55. PubMed ID: 31640913
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reply from authors re: Guillaume Ploussard, James W. Catto. The quest for an optimal definition of prostate-specific antigen failure following radical prostatectomy: the risk of not seeing the forest for the trees. Eur Urol 2014;66:211-13: Identifying the candidates for early salvage therapy after radical prostatectomy.
    Mir MC; Stephenson AJ
    Eur Urol; 2014 Aug; 66(2):213. PubMed ID: 24176596
    [No Abstract]   [Full Text] [Related]  

  • 51. Re: Alessandro Sciarra, Valeria Panebianco, Stefano Salciccia, et al. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Eur Urol 2008;54:589-600.
    Casciani E; Bertini L; Gualdi G
    Eur Urol; 2009 Jan; 55(1):e2-3; author reply e4-5. PubMed ID: 18572302
    [No Abstract]   [Full Text] [Related]  

  • 52. Reply to Francesco Montorsi and Giorgio Gandaglia's letter to the editor re: Georgios Gakis, Stephen A. Boorjian, Alberto Briganti, et al. The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature. Eur urol 2014;66:191-9.
    Gakis G; Stief CG
    Eur Urol; 2014 Dec; 66(6):e109-10. PubMed ID: 25204223
    [No Abstract]   [Full Text] [Related]  

  • 53. The Role of Magnetic Resonance Image Guided Prostate Biopsy in Stratifying Men for Risk of Extracapsular Extension at Radical Prostatectomy.
    Raskolnikov D; George AK; Rais-Bahrami S; Turkbey B; Siddiqui MM; Shakir NA; Okoro C; Rothwax JT; Walton-Diaz A; Sankineni S; Su D; Stamatakis L; Merino MJ; Choyke PL; Wood BJ; Pinto PA
    J Urol; 2015 Jul; 194(1):105-111. PubMed ID: 25623751
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care?
    Delongchamps NB; Lefèvre A; Bouazza N; Beuvon F; Legman P; Cornud F
    J Urol; 2015 Apr; 193(4):1198-204. PubMed ID: 25451824
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reply to Francesco Montorsi, Nicola Fossati, Carlo A. Bravi, Giorgio Gandaglia, Nazareno Suardi, and Alberto Briganti's Letter to the Editor re: Sophie Knipper, Luigi Ascalone, Benjamin Ziegler, et al. Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy. Eur Urol 2021;79:537-44. Surgical Treatment of Local Recurrence Following Radical Prostatectomy: Reality or Illusion?
    Knipper S; Maurer T
    Eur Urol; 2021 May; 79(5):e134. PubMed ID: 33579574
    [No Abstract]   [Full Text] [Related]  

  • 56. Prediction of biochemical recurrence in prostate cancer patients who underwent prostatectomy using routine clinical prostate multiparametric MRI and decipher genomic score.
    Jambor I; Falagario U; Ratnani P; Perez IM; Demir K; Merisaari H; Sobotka S; Haines GK; Martini A; Beksac AT; Lewis S; Pahikkala T; Wiklund P; Nair S; Tewari A
    J Magn Reson Imaging; 2020 Apr; 51(4):1075-1085. PubMed ID: 31566845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of Magnetic Resonance Imaging and Transrectal Ultrasound Informed Prostate Biopsy for Prostate Cancer Diagnosis in Biopsy Naïve Men: A Systematic Review and Meta-Analysis.
    Goldberg H; Ahmad AE; Chandrasekar T; Klotz L; Emberton M; Haider MA; Taneja SS; Arora K; Fleshner N; Finelli A; Perlis N; Tyson MD; Klaassen Z; Wallis CJD
    J Urol; 2020 Jun; 203(6):1085-1093. PubMed ID: 31609177
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor contact length of prostate cancer determined by a three-dimensional method on multiparametric magnetic resonance imaging predicts extraprostatic extension and biochemical recurrence.
    Miyamoto S; Goto K; Honda Y; Terada H; Fujii S; Ueno T; Fukuoka K; Sekino Y; Kitano H; Ikeda K; Hieda K; Inoue S; Hayashi T; Teishima J; Takeshima Y; Yasui W; Awai K; Matsubara A
    Int J Urol; 2021 Oct; 28(10):1012-1018. PubMed ID: 34227174
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predicting Pathological Tumor Size in Prostate Cancer Based on Multiparametric Prostate Magnetic Resonance Imaging and Preoperative Findings.
    Pooli A; Johnson DC; Shirk J; Markovic D; Sadun TY; Sisk AE; Mohammadian Bajgiran A; Afshari Mirak S; Felker ER; Hughes AK; Raman SS; Reiter RE
    J Urol; 2021 Feb; 205(2):444-451. PubMed ID: 33026934
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reply to Alberto Briganti, Giorgio Gandaglia, Markus Graefen, Steven Joniau, R. Jeffrey Karnes, and Francesco Montorsi's Letter to the Editor re: Jean F.P. Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial. Eur Urol 2021;79:595-604. Time for a Change? Clinically Meaningful Reasons Why We Will Continue Performing Extended Pelvic Lymph Node Dissection in Selected Patients with Prostate Cancer.
    Lestingi JFP; Trinh QD; Coelho RF; Pontes J; Bastos DA; Nahas WC
    Eur Urol; 2021 Jun; 79(6):e184-e185. PubMed ID: 33685836
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.